Zim Receives 3rd Line ARVs For Children and Adolescents

JANSSEN Pharmaceutical Companies a subsidiary of Johnson & Johnson has donated a sizable quantity of Third-line Antiretroviral (ARV) drugs to Zimbabwe as part of its efforts to address the huge ARV drug resistance burden prevalent in children and young people. By Michael Gwarisa Through a program dubbed the New Horizons Collaborative, an integrated approach to improving pediatric HIV care, a total of 5000 children from the SADC region are set to benefit. Through the program, Janseen provides Darunavir and Etravirine, including child friendly formulations, free of charge to eligible countries…

Share
Read More